212 related articles for article (PubMed ID: 18816608)
1. Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program.
Mastalski K; Coups EJ; Ruth K; Raysor S; Giri VN
Cancer; 2008 Nov; 113(9):2559-64. PubMed ID: 18816608
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer screening in high-risk men: African American Hereditary Prostate Cancer Study Network.
Weinrich SP
Cancer; 2006 Feb; 106(4):796-803. PubMed ID: 16411222
[TBL] [Abstract][Full Text] [Related]
3. Association between family history of prostate cancer and positive biopsies in a Brazilian screening program.
Muller RL; Faria EF; Carvalhal GF; Reis RB; Mauad EC; Carvalho AL; Freedland SJ
World J Urol; 2013 Oct; 31(5):1273-8. PubMed ID: 22820620
[TBL] [Abstract][Full Text] [Related]
4. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in prostate cancer screening by family history.
Drake BF; Lathan CS; Okechukwu CA; Bennett GG
Ann Epidemiol; 2008 Jul; 18(7):579-83. PubMed ID: 18486487
[TBL] [Abstract][Full Text] [Related]
6. Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making.
Woods-Burnham L; Stiel L; Wilson C; Montgomery S; Durán AM; Ruckle HR; Thompson RA; De León M; Casiano CA
Am J Mens Health; 2018 Jul; 12(4):751-759. PubMed ID: 29658371
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Prostate-Specific Antigen Test Use in the U.S., 2005-2015.
Berkowitz Z; Li J; Richards TB; Marcus PM
Am J Prev Med; 2017 Dec; 53(6):909-913. PubMed ID: 29051016
[TBL] [Abstract][Full Text] [Related]
8. Determinants of Prostate Specific Antigen Screening among Black Men in the United States in the Contemporary Era.
Sammon JD; Dalela D; Abdollah F; Choueiri TK; Han PK; Hansen M; Nguyen PL; Sood A; Menon M; Trinh QD
J Urol; 2016 Apr; 195(4 Pt 1):913-8. PubMed ID: 26598427
[TBL] [Abstract][Full Text] [Related]
9. Recruitment strategies and comparison of prostate cancer-specific clinical data on African-American and Caucasian males with and without family history.
Mandal DM; Sartor O; Halton SL; Mercante DE; Bailey-Wilson JE; Rayford W
Prostate Cancer Prostatic Dis; 2008; 11(3):274-9. PubMed ID: 18268528
[TBL] [Abstract][Full Text] [Related]
10. Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study.
Jenkins KR; Oyekunle T; Howard LE; Wiggins EK; Freedland SJ; Allott EH
Cancer Causes Control; 2021 Apr; 32(4):337-346. PubMed ID: 33532986
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population.
Kaplan DJ; Boorjian SA; Ruth K; Egleston BL; Chen DY; Viterbo R; Uzzo RG; Buyyounouski MK; Raysor S; Giri VN
BJU Int; 2010 Feb; 105(3):334-7. PubMed ID: 19709072
[TBL] [Abstract][Full Text] [Related]
12. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
13. Is prostate cancer different in black men? Answers from 3 natural history models.
Tsodikov A; Gulati R; de Carvalho TM; Heijnsdijk EAM; Hunter-Merrill RA; Mariotto AB; de Koning HJ; Etzioni R
Cancer; 2017 Jun; 123(12):2312-2319. PubMed ID: 28436011
[TBL] [Abstract][Full Text] [Related]
14. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
15. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
Dall'Era MA; deVere-White R; Rodriguez D; Cress R
Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies.
Shelton JB; Barocas DA; Conway F; Hart K; Nelson K; Richstone L; Gonzalez RR; Raman JD; Scherr DS
Urology; 2005 May; 65(5):931-6. PubMed ID: 15882726
[TBL] [Abstract][Full Text] [Related]
17. Racial differences in screening for prostate cancer in the elderly.
Gilligan T; Wang PS; Levin R; Kantoff PW; Avorn J
Arch Intern Med; 2004 Sep; 164(17):1858-64. PubMed ID: 15451760
[TBL] [Abstract][Full Text] [Related]
18. Family history, perceived risk, and prostate cancer screening among African American men.
Bloom JR; Stewart SL; Oakley Girvan I; Banks PJ; Chang S
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2167-73. PubMed ID: 17119042
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
[TBL] [Abstract][Full Text] [Related]
20. Family history in the Finnish Prostate Cancer Screening Trial.
Saarimäki L; Tammela TL; Määttänen L; Taari K; Kujala PM; Raitanen J; Auvinen A
Int J Cancer; 2015 May; 136(9):2172-7. PubMed ID: 25274038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
